Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 2/3 2Phase NA 1Phase 4 1Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Adenomatous Polyposis Coli 2Adenoma 2Polyps 1Neoplastic Syndromes, Hereditary 1Intestinal Neoplasms 1Intestinal Diseases 1Genetic Diseases, Inborn 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Duodenal Neoplasms 1Digestive System Neoplasms 1Digestive System Diseases 1Adenomatous Polyps 1

Interventions

Cisplatin 98Gemcitabine 66Paclitaxel 62Carboplatin 60Fluorouracil 59Docetaxel 59Capecitabine 59Oxaliplatin 56Cyclophosphamide 54Radiotherapy 50Drug Therapy 46Bevacizumab 38pembrolizumab 35Dexamethasone 33Magnetic Resonance Spectroscopy 32Leucovorin 32Doxorubicin 31Cytarabine 27Etoposide 26Pemetrexed 25Nivolumab 24Methotrexate 24Radiation 20venetoclax 18Vincristine 18apatinib 17Trastuzumab 17Rituximab 17Prednisone 17Letrozole 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Ursodeoxycholic Acid × Clear all
NCT00808743 2013-05-16

PreDuoFAP

Radboud University Medical Center

Phase 2/3 Completed
37 enrolled
Gastrointestinal

Adenoma, Digestive System Diseases, Digestive System Neoplasms, Duodenal Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplastic Syndromes, Hereditary, Adenomatous Polyposis Coli, Polyps, Adenomatous Polyps, Genetic Diseases, Inborn

NCT00134758 2009-07-29

Ursodeoxycholic Acid in the Treatment of Duodenal Adenomas in Familial Adenomatous Polyposis (FAP) Patients

Assistance Publique - Hôpitaux de Paris

Phase 2/3 Unknown
90 enrolled
Gastrointestinal

Adenoma, Adenomatous Polyposis Coli

Data powered by HemOnc (CC BY 4.0) Colophon âš¡